Ticino: the life science valley in the heart of Europe

Similar documents
Life sciences and health technologies. A wealth-generating sector and a creator of prosperity for Quebec

FOREIGN DIRECT INVESTMENT IN CATALONIA AND BARCELONA

Ireland Future R&D Investment in a Small Open Economy Opportunities and Threats. Third KEI Workshop Helsinki

Valeria FASCIONE. Regional Minister for Internationalization, Innovation and Startups Campania Region (Italy)

Business Seminar Canton of Vaud/Aeropole Competence Center in aviation and aerospace

England s Economic Heartland

Bullpup Scientific. Technology & Product: Company at a Glance: Goals

Innovation and Technology in Spain

City of Mississauga International Marketing Strategy Canada s Global Investment Destination. April 23, 2012

Novartis Business Services HR University Relations. Regulatory Affairs. Graduate & Postgraduate Program

INTERREG ATLANTIC AREA PROGRAMME CITIZENS SUMMARY

2016 ANNUAL RESULTS HUMAN RESOURCES MANAGEMENT 6 APRIL, 2017 STUDIO HARCOURT 6 RUE DE LOTA PARIS 16 E 10H30

FOREIGN DIRECT INVESTMENT

PMDA EPOCH Toward 2020

Time to invest properly!

2017 HALF-YEAR RESULTS STUDIO HARCOURT 6 RUE DE LOTA PARIS 16 E SEPTEMBRE 14, H30

LEVERAGING TRADE AND INVESTMENT TO BUILD A STRONGER ECONOMY

The place of Bioscience in the UK s Industrial Strategy

Business Environment and Knowledge for Private Sector Growth: Setting the Stage

Towards a RIS3 strategy for: Wallonia. Seville, 3 May 2012 Directorate For Economic Policy Mathieu Quintyn Florence Hennart

A different vision of the pharmaceutical industry

Smart Specialisation in the Region of Attica

Australian Biomedical & Healthcare

Federal Department of Foreign Affairs FDFA Consulate General of Switzerland Ho Chi Minh City. Higher education and Research in Switzerland

International Sourcing measurement issues. Peter Bøegh Nielsen Statistics Denmark

South Carolina Trade Mission to South Korea and Japan September 5-11, 2018

How to obtain a Startup VISA in Italy

What future for the European combat aircraft industry?

ETH Zurich Cooperation with China

Integra. International Corporate Capabilities th Street NW, Suite 555W, Washington, DC, Tel (202)

GREATER CINCINNATI: A MANUFACTURING POWERHOUSE

Activities and instruments of the CTI Workshop A for Science Administrators of the Asia-Pacific Region

presents OHIO biomedical and pharma career fair April 15 2pm 6pm Columbus, Ohio Exhibitor Booklet

Belgium Published on Innovation Policy Platform (

Young Entrepreneurship as the key to a sustainable and growing economic future

Swiss Polish Roundtable on Innovation. Wädenswil / Switzerland I 21 October 2014 Thomas Meier I Cluster Manager

Where the World is Going


Economic Development and The Role of Clusters: Implications for Policy

METS Ignited Mining Equipment Technology Services

Hamburg and its Cluster policy

Inclusive growth in an advanced, innovative economy The Case Study of Israel Mr. Amit Lang Director General of the Ministry of Economy Israel

Access to finance for innovative SMEs

Foreign investments in Scandinavia. Attorney-at-law Henrik Nilsson Advokatfirman Allians Stockholm, Sweden

Pre-Budget Submission. Canadian Chamber of Commerce

Introduction. Artex Value. Our Competencies. Our Strategy

MSD GRADUATE PROGRAMME MSD - INVENT. IMPACT. INSPIRE 1

Life Sciences in the Czech Republic.

Chapter 2. Business and Investment Environment Doing Business in Malta 13

Japanese Investment in CE-SEE and. JETRO s Activities in the CE-SEE

The Enterprise Europe Network

Swiss Education, Research & Innovation and its International Dimension

BETTER ACCESS. Wallonia European Creative District. Forget conventions consider rules be creative.

Economic Vision for Malta

German-Italian Innovation Conference (Berlin, Italian Embassy, 29th November 2017)

BELGIAN EU PRESIDENCY CONFERENCE ON RHEUMATIC AND MUSCULOSKELETAL DISEASES (RMD)

Massachusetts Programs & Initiatives Advancing the Biopharmaceutical Industry

A Career in Big Pharma. Beatrice Tilt, GSK

COUNTRY PROFILE. Luxembourg

Taiwan and Los Angeles County: Growing Together

Financial Instruments in Tourism Development

Carlos Honorato Comandari

Board of Investment Thailand Policies and Incentives. Ms. Vibulphan Juntarashote Sydney, Australia July 24, 2006

UNIVERSITÉ DE LORRAINE

ISRAEL & GERMANY: Strong Partners Strong Business

Manpower Employment Outlook Survey Ireland. A Manpower Research Report

THIS IS THE LARGEST GATHERING OF ALL LIFE SCIENCES SPECIALISTS IN THE ENTIRE CENTRAL AND EASTERN EUROPE.

Digital & Tech Conference STATE OF DIGITAL INDUSTRY

Priorities for exit negotiations

Forward-Looking Statements

Global Value Chains: Impacts and Implications. Aaron Sydor Office of the Chief Economist Foreign Affairs and International Trade Canada

The Barcelona model of City Marketing & Branding. Area of Economy, Enterprise & Employment Barcelona City Council

SME Internationalisation: Characteristics, Barriers and Policy Options

OPORA RUSSIA ALL-RUSSIAN NON-GOVERNMENTAL ORGANIZATION OF SMALL AND MEDIUM-SIZED BUSINESS SERGEY R. BORISOV

( ) Page: 1/24. Committee on Subsidies and Countervailing Measures SUBSIDIES

UNIÓ DE POLÍGONS INDUSTRIALS DE CATALUNYA FOREIGN BUSINESS AND INVESTMENT DOSSIER

Zurich s Research Intensive Universities and FP9. Position of ETH Zurich and the University of Zurich (UZH) Date 6 June 2017.

5. Trends in international sourcing. Authors René Bongard Bastiaan Rooijakkers Fintan van Berkel

OPEN. for your business

International Benchmarking of Countries Policies and Programs Supporting SME Manufacturers BY STEPHEN J. EZELL AND DR. ROBERT D.

Context. The Strategy Europe 2020: Smart growth. Sustainable growth. Inclusive growth

COSME Programme for the Competitiveness of Enterprises and SMEs. Enterprise Europe Network

EXPORT PROMOTION AND INVESTMENT ATTRACTION IN THE GLOBAL SERVICES OUTSOURCING SECTOR. Fabrizio Opertti Chief Trade and Investment Division

Mediwales Finance and Funding Event:

Thessaloniki Innovation Zone: Evolution to sector-specific

Exploiting International Food & Drink Opportunities. Dr David Carson

2014 ACTIVITY REPORT 2014

Submission to the R&D tax environment review

Prosperity through Innovation and Sustainability

NOVA SCOTIA BUSINESS INC. Business Plan

Role and Vision of PMDA

Science, Technology and Innovation for Make in India: Issues and Conditions

The Americas Competitiveness Forum II Executive Report September 1, 2008

Developing regional industry clusters When to compete; when to collaborate the experience of Piemonte, Italy

Spotlight on South Africa

Minor changes in the following text might apply. For the updated version, please always refer to the web pages.

A Worldwide Network of Quality Accounting Firms

OUTSOURCING SURVEY. This year we had 315 industry professionals respond

Latest statistics August 2015

Horizon 2020 Financial Instruments for the Private Sector, Especially SMEs An Overview

Transcription:

ma Industria

Ticino: the life science valley in the heart of Europe The Association at present counts 27 member companies, with a combined workforce of over 2500 employees and a total annual turnover of approximately 2.3 Billion Swiss Francs (>80% export), accounting for approximately 8% of the cantonal GNP. The actual number of personnel of the companies associated with Farma Industria Ticino averages at 100 employees and is therefore higher than the average associated with the entire industrial sector of Ticino. Several investments accounting for almost a half billion Swiss francs have been planned for Ticino in the next three years, mainly in R&D and innovation. Representing the vast majority of the companies active in this Italian speaking part of Switzerland, FIT has a great network of know-how and access to skilled and qualified, multilingual human resources, due to its strategical and privileged geographical position that makes Ticino a natural connection between northern and southern Europe. In Ticino, the presence of world-class high schools and research institutes integrated into the enterprise system and the proximity to the Swiss and Northern Italy Universities and pharmaceutical expertise provide a significant technical, scientific, logistic and cultural asset. A main area of focus to which Farma Industria Ticino contributes with its own expertise is vocational training. A commitment also based on the constant need to discover and train future co-workers. The Association s activity in this specific area hinges on the promotion of all training opportunities which are tied to careers in the sector, and targeted at new generations of technicians, organizing introductory courses aimed at young people who are serving apprenticeships in the professions of chemical laboratory technician, biology laboratory technician and manufacturing operators. For the middle management teams, mini-mba training courses in pharmaceutical management are organized in collaboration with a local university school (SUPSI). Quality, technology, innovation and sustainable growth represent the core assets of our industry. Several companies have been certified, in addition to Swissmedic, by many foreign authorities such as but not limited to US-FDA, Brazilian Anvisa, Japanese PMDA, Korean sfda and participate in programs such as OSHA, ISO, responsible care and certified sustainability. Activities of our associates range from preclinical and clinical drug development to chemical and formulation process development to industrial manufacturing of different classes of APIs and of a great variety of Drug Products forms. The vast majority of FIT companies also offer services such as Contract Research and Manufacturing Organizations. Association of chemical and pharmaceutical industries in the Swiss canton of Ticino Corso Elvezia 16 Casella postale 5130 CH-6901 Lugano Tel.: +41 91 911 84 86 Fax: +41 91 923 46 36 info@farmaindustriaticino.ch www.farmaindustriaticino.ch Attention to quality of life is of paramount importance in Ticino and is reflected in the personal security provided to citizens, the quality of the health system, the efficiency of public transport and of financial services These distinguishing social factors, together with a mild Mediterranean climate and a spectacular natural landscape, represent great assets for all of our associates, our people, our partners and our customers. 1 2

Bellinzona IRB Institute for Research in Biomedicine Canton Ticino: platform for international business Ascona Locarno SUPSI University of Applied Sciences and Arts of Southern Switzerland Fondazione AGIRE USI University of Southern Switzerland Lugano Located just south of the beautiful Swiss Alps, Ticino is the Italian-speaking region of Switzerland. Its strategic geographic position represents a bridge between northern and southern Europe and between two of the strongest and most dynamic economic areas in Europe: Lombardy with Milan at its heart and the Zurich region. In a unique harmony it unites the Swiss accuracy and reliability with the Italian flexibility, resulting in an excellent combination of creativity and sound economic development. Thanks to the mild climate and the attractive landscapes, Ticino is one of the furthermost touristic locations in Switzerland, but at the same time it showcases a wide array of business activities. The local economy ideally balances the industrial and the service sectors. Alongside a leading tertiary sector (Lugano is the third finance market in Switzerland) there is a solid industrial sector with export-oriented, internationally competitive and highly innovative companies. The backbone of the industrial sector, composed by a number of SMEs in the fields of life sciences, mechanics and electronics, has recently been complemented by rising new sectors like renewable energies, advanced logistics, and the fashion industry. In this latter, several top brands found ideal conditions for their regional or worldwide headquarters. In the life sciences field an important role is played by the pharma industry, where top quality niche-producers cover the entire supply chain. The success of the local industrial companies is based, on one hand, on the advantages offered by the Swiss system in terms of exceptional political and institutional stability, a competitive and flexible labour market, complete security, and a mild taxation. On the other hand, the availability of highly skilled labour force with exceptional multilingual skills and the opportunity for companies to collaborate with top notch research institutes stimulates the local enterprises to constantly invest in innovation and remain competitive with a cutting edge technology. The local authorities are equipped to advise and support business ventures at their various stages. Particular attention is paid to the general framework conditions, in order to provide a business-friendly and unbureaucratic environment. In addition, the public administration is always available for a smooth and prompt resolution of any procedural issue that might arise. The Economic Promotion Agency informs foreign companies about the business opportunities in our region and simplifies their settlement by providing practical and direct support.start-ups and innovative entrepreneurial projects are supported by the AGIRE Foundation through coaching, technology advisory, networking. AGIRE promotes and fosters the transfer of technology between companies and the academic or research centers. AGIRE manages the Technology Park (Tecnopolo Ticino that offers office spaces and support to innovative companies targeting international markets from Ticinoso far more than 50 companies have settled there. Additional locations, dedicated to specific business sectors, including biotech and medtech, are in preparation. TiVENTURE is a newly established venture capital fund that invests in innovative companies with high growth potential strongly collaborating with the local stakeholders of the local innovation ecosystem. Existing companies and newly settled enterprises active in manufacturing and innovative fields are also offered various direct incentives and support mainly aimed at fostering R&D, innovation and export. Tecnopolo Ticino Stabile Suglio, Entrata EST, Via Cantonale 18, 6928 Manno - Tel. +41 (0)91 610 27 10, info@agire.ch, www.agire.ch Dipartimento delle finanze e dell economia Divisione dell economia Divisione dell economia Ufficio per lo sviluppo economico Viale Stefano Franscini 17, CH-6501 Bellinzona - Tel. +41 (0)91 814 35 41, info@copernico.ch, www.copernico.ch 7 Chiasso 4

2 12 Farma Industria Ticino (FIT), the association of chemical and pharmaceutical industries in the Swiss Canton of Ticino, is a private organization founded in 1980 with headquarters in Lugano. Ascona 21 Locarno 19 18 16 17 10 4 1 20 7 6 14 13 26 22 5 22 24 27 15 11 23 9 Lugano 25 Bellinzona Index 1 Alpex Pharma SA, Mezzovico 2 Alpine Foundation for Life Science, Olivone 3, Balerna 4 Bracco Suisse SA, Manno 5 Cerbios - Pharma SA, Barbengo 6, Lugano 7, Manno 8 ECSA Chemicals AG, Balerna 9, Lugano 10, Bioggio 11, S. Antonino 12, Biasca 13, Pazzallo 14, Pambio Noranco 15 Ingenus Pharmaceuticals Sagl, Barbengo 16 KerrHawe SA, Bioggio 17, Riazzino 18, Monteggio 19, Ponte Cremenaga 20, Bedano 21 Pharmanalytica SA, Locarno 22, Pazzallo 23, Lugano 24, Manno 25, Mendrisio 26, Barbengo 27, Cadempino 8 Chiasso 3 5 6

Member companies competences Main Activity Licensing-In Licensing-Out Co-development Trading Drug Product CMO Drug Substance CMO Therapeutic Areas Other CMO Activities Others Oncology Dermatology Gastrointestinal Respiratory Ophtalmology Cancer supportive therapy CNS Other Markets Markets EU Top 5 Rest of Europe USA and Canada Japan LATAM MENA BRICS ASEAN Australia Alpex Pharma SA Alpex Pharma Alpine Foundation for Life Science Bracco Suisse SA Emanuele Centonze SA ECSA Chemicals AG Licensing-In Licensing-Out Co-development Trading Drug Product CMO Drug Substance CMO Other CMO Activities Cancer supportive therapy Cardiology Cardiovascular CNS Therapeutic Areas Dermatology Diabetes Gastrointestinal Gynaecology Oncology Ophtalmology Orthopedics Pain Respiratory Other therapeutic areas CH EU Rest of Europe USA and Canada Japan LATAM MENA BRICS ASEAN Australia Other market Ingenus Pharmaceuticals Sagl Pharmintraco Sagl Yes Partially 7 8

Member companies competences Main Activity Drug Stages Licensing-In Licensing-Out Co-development Trading Drug Product CMO Drug Substance CMO Drug Product Forms Other CMO Activities Others Therapeutic Areas Oncology Dermatology Gastrointestinal Other Respiratory CMO Activities Ophtalmology Cancer supportive therapy CNS Other Markets Certifications EU Top 5 Rest of Europe USA and Canada Japan LATAM MENA BRICS ASEAN Australia Alpex Pharma Emanuele Centonze SA Pre-clinical Phase I - Phase III Registration Market Generic Plus (505B2) Generic Life cycle management Aerosol Inhaler Injectable Oral (solid) Oral (liquid) Spray Topical Other drug form Analytical Services Co-development Contract Micronization Micronization Yes Partially 9 10 Pre-formulation Spray-Drying Other cmo activities Alpex Pharma SA Alpine Foundation for Life Science Bracco Suisse SA ECSA Chemicals AG Swissmedic FDA European Medicines Agency Korea FDA ISO 9001 ISO 14001 PMDA Anvisa AIFA GRI Other Certifications Ingenus Pharmaceuticals Sagl Pharmintraco Sagl

Can he inherit your ambition as well as your wealth? Discover how Credit Suisse can help you plan your wealth for the next generation at credit-suisse.com/successionplanning